Back to all Resources

Infographics
September 5, 2019

Mental Health Infographic: Real-time Patient Insights from Medisafe

Highlights from the Mental Health Infographic

  • In general, mental illness med adherence is higher in Europe than the United States
  • Weekends prove challenging for medication adherence
  • Unlike many therapeutic areas, medication adherence remains strong during the evening hours
  • Mental illness adherences declines up to 3%
    when more than one med is taken
  • The most common pairing in mental illness is with Bupropion, the generic antidepressant that also goes by the brand names Wellbutrin, Zyban and Aplenzin
  • Of the top 10 mental illness drugs with the highest reported adherence, Janssen holds two spots – Invega and Risperdal

What insights can we discover about your brand? Contact us to find out!

‍

Back to all Resources

Article
Dec 10, 2025
Transforming Breast Cancer Care: Proven Adherence Gains for Pharma Execs

Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 breast cancer–related deaths projected in the United States in 2025 (American Cancer Society, 2025). Despite advances in targeted oral therapies for extended adjuvant treatment, real‐world studies find that up to 50% of patients discontinue or skip doses, undermining efficacy (Mayo Clinic, 2024).

Watch Webinar

Article
Oct 22, 2025
Pharmaceutical Companies Can Now Use AI to Streamline the Patient Experience with Medisafe and Infinitus

Leading pharmaceutical companies are now using AI to help healthcare providers simplify and streamline the patient experience for specialty medications, which can be difficult to access, adhere to, and afford.

Watch Webinar

Article
Dec 22, 2025
Medisafe Empowers Pharma: Elevating Cardiovascular Drug Launches

Medisafe has pioneered an ecosystem of digital solutions aimed at addressing critical Pharma challenges. The Medisafe Digital Companion stands out as a comprehensive tool that provides personalized medication management, reminders, and educational content. Research indicates that Medisafe users exhibit improved medication adherence rates, with some studies showing an adherence rate increase of over 20%.

Watch Webinar

Build a smarter patient engagement strategy

See how Medisafe helps pharmaceutical teams activate patients, improve adherence, and measure outcomes across their portfolio.

Request a Demo
Platform
For PharmaFor ProvidersFor PatientsDownload App
Therapeutic Areas
CardiovascularInflammatoryMental HealthMetabolic / GLP-1NeurologyOncology
Resources
ResearchArticlesInfographicsMediscoveries
Company
About MedisafeCareersNews & EventsContact

© 2026 Medisafe. All rights reserved.

Privacy PolicyTerms & ConditionsConsumer Health Data Policy